These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3148209)

  • 1. A comparative study of venous occlusion and DDAVP stimulated fibrinolysis in normolipidemic subjects.
    Smith P; Arnesen H; Dahl KH; Nilsen DW; Opstad T; Andersen P
    Thromb Res; 1988 Dec; 52(6):655-60. PubMed ID: 3148209
    [No Abstract]   [Full Text] [Related]  

  • 2. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Knoers N; Brommer EJ; Willems H; van Oost BA; Monnens LA
    Nephron; 1990; 54(4):322-6. PubMed ID: 2109264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue plasminogen activator in human plasma measured by radioimmunoassay.
    MacGregor IR; Prowse CV
    Thromb Res; 1983 Aug; 31(3):461-74. PubMed ID: 20218002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. t-PA activity elicited by venous occlusion or DDAVP infusion does not produce plasmin activity in normal subjects.
    Cugno M; Uziel L; Marongiu F; Bottasso B; Legnani C; Palareti G
    Thromb Res; 1990 Sep; 59(6):1007-11. PubMed ID: 2148226
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired fibrinolytic response to DDAVP in patients with von Willebrand's disease.
    Sultan Y; Loyer F; Venot A
    Nouv Rev Fr Hematol (1978); 1992; 34(1):55-60. PubMed ID: 1523100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
    Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
    Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects.
    MacGregor IR; Roberts EM; Prowse CV; Broomhead AF; Ozolins M; Litka P
    Thromb Haemost; 1988 Feb; 59(1):34-9. PubMed ID: 3129807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus.
    Vicari AM; Viganó D'Angelo S; Testa S; Comi G; Galardi G; Orsi E; D'Angelo A
    Horm Metab Res; 1992 Nov; 24(11):516-9. PubMed ID: 1452117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to fibrinolytic activity and factor VIII-related antigen to stimulation with desmopressin in hyperlipoproteinemia.
    Brommer EJ; Gevers Leuven JA; Barrett-Bergshoeff MM; Schouten JA
    J Lab Clin Med; 1982 Jul; 100(1):105-14. PubMed ID: 6806418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal homeostasis of fibrinolysis in nephrogenic diabetes insipidus in spite of defective V2- receptor-mediated responses of tissue plasminogen activator release.
    Brommer EJ; Brink H; Derkx FH; Schalekamp MA; Stibbe J
    Eur J Clin Invest; 1990 Feb; 20(1):72-8. PubMed ID: 2138555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive effect of dDAVP and standard heparin in increasing plasma t-PA.
    Agnelli G; Levi M; Cosmi B; ten Cate JW; Nenci GG
    Thromb Haemost; 1989 Jun; 61(3):507-10. PubMed ID: 2508260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the fibrinolytic response to desmopressin acetate (DDAVP) infusion versus venous occlusion in patients with coronary artery disease.
    Duprez D; Baele G; De Buyzere M; Vandenbroecke P; Clement DL
    Eur Heart J; 1991 Jul; 12(7):800-2. PubMed ID: 1909628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental studies of the liberation of plasminogen activator by DDAVP].
    Jablonowski C; Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):567-74. PubMed ID: 6083928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different tissue plasminogen activator release in the arm and leg during venous occlusion is equalized after DDAVP infusion.
    Keber D; Stegnar M; Kluft C
    Thromb Haemost; 1990 Feb; 63(1):72-5. PubMed ID: 2111049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to DDAVP stimulation in thirteen patients with Buerger's disease.
    Siguret V; Alhenc-Gelas M; Aiach M; Fiessinger JN; Gaussem P
    Thromb Res; 1997 Apr; 86(1):85-7. PubMed ID: 9172291
    [No Abstract]   [Full Text] [Related]  

  • 17. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    Agents Actions Suppl; 1992; 38 ( Pt 2)():292-8. PubMed ID: 1462834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolytic response in normal subjects to venous occlusion and DDAVP infusion.
    Cugno M; Uziel L; Fabrizi I; Bottasso B; Maggiolini F; Agostoni A
    Thromb Res; 1989 Dec; 56(5):625-34. PubMed ID: 2516662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XII activation after DDAVP.
    Patrassi GM; Sartori MT; Lazzaro AR; Viero ML; Boscaro M; Girolami A
    Thromb Res; 1990 Jun; 58(5):531-2. PubMed ID: 2368038
    [No Abstract]   [Full Text] [Related]  

  • 20. A dynamic test to investigate potential tissue plasminogen activator activity. Comparison of deamino-8-D-argininevasopressin with venous occlusion in normal subjects and patients.
    Sultan Y; Harris A; Strauch G; Venot A; De Lauture D
    J Lab Clin Med; 1988 Jun; 111(6):645-53. PubMed ID: 3131470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.